| Common Colds Patents of George A. Eby |
Cure for Common Cold - U.S. Patent 5,409,905.
Cure for Common Cold - U.S. Patent Number 5,409,905
Flavor Stable Zinc Acetate Compositions for Oral Absorption - European patent application WO9210997.
Flavor Stable Zinc Acetate Compositions for Oral Absorption - Canadian patent CA 2099670
General Method of Shortening the Duration of Common Colds by Application of Medicaments to Tissues of Oral Cavity U. S. Patent Number 5,286,748
Flavor Stable Zinc Acetate Compositions for Oral Absorption U. S. Patent Number 5,095,035
Flavor Masked Ionizable Zinc Compositions for Oral Absorption U. S. Patent Number 5,002,970.
Method for Reducing the Duration of the Common Cold [improved]) - U. S. Patent Number 4,956,385
Method of Reducing the Duration of Common Colds U. S. Patent Number Re. 33,465
Seeing and understanding what to expect from other zinc lozenges is important viewing. Did you know that zinc lozenges containing citric acid or glycine are not significantly effective? See this data to understand that there are no active ingredients at physiologic pH for zinc lozenges having as flavorings or flavor-masks citric acid (citrate), glycine (glycinate), and therefore no significant activity. These lozenges predominate in the U. S. market because they taste like candy not medicine. Eby's ColdCure zinc acetate lozenges taste like medicine because they are medicine..